Pharma organizations need to make decisions faster as markets shift, competition intensifies, supply and demand signals become more complex, and lifecycle value comes under pressure. Yet traditional analysis cycles still rely on static, periodic updates, which makes it harder to keep pace with how markets, assets and portfolios actually evolve.
Agentic AI enables teams to move from reactive analysis to more continuous, insight-led decision-making. It brings together fragmented market, clinical, patient, supply and customer data and turns it into clearer guidance across the product lifecycle.
Real-world experience shows this shift is already underway:
• Complex analyses that once took 3+ days can now be delivered in seconds
• Data can be connected more easily across the full lifecycle, from early development to post-launch
• AI-driven approaches are creating new opportunities, from improving field force effectiveness to identifying previously undiagnosed rare disease patients in months
Join this session to:
• Understand how agentic AI can support faster, more agile and more precise decisions across the pharma lifecycle
• See where AI and advanced analytics can create value across the lifecycle, from pipeline and launch planning to LOE and lifecycle management
• Explore how agentic AI unifies global market signals into decision-ready market intelligence
Drawing on real-world examples, the session will show how integrated data and natural-language interaction can turn fragmented signals into timely insights and recommendations, helping organizations act faster and with greater confidence.
